Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy
- 15 May 2022
- journal article
- research article
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 103 (10) , 486-494
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Effect of background parenchymal enhancement on breast cancer detection with magnetic resonance imagingDiagnostic and Interventional Imaging, 2016
- Background Parenchymal Enhancement on Preoperative Magnetic Resonance ImagingMedicine, 2016
- Effect of Menstrual Cycle Phase on Background Parenchymal Uptake at Molecular Breast ImagingAcademic Radiology, 2015
- Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast CancerRadiology, 2015
- Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyTranslational Oncology, 2015
- Use of and Mortality After Bilateral Mastectomy Compared With Other Surgical Treatments for Breast Cancer in California, 1998-2011JAMA, 2014
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisThe Lancet, 2014
- MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant ChemotherapyPLOS ONE, 2013
- Biomarkers for the clinical management of breast cancer: International perspectiveInternational Journal of Cancer, 2012
- Breast Stromal Enhancement on MRI Is Associated with Response to Neoadjuvant ChemotherapyAmerican Journal of Roentgenology, 2008